Loading clinical trials...

COMPLETEDNA

Effect of Coffeeberry on Mood, Motivation and Cognitive Performance

NCT04974606•PepsiCo Global R&D

Summary

The primary purpose is to test the short-term effects of the acute consumption of two novel beverages made from coffeeberries, the fruit of the coffee plant (Coffea arabica) benchmarked against caffeine on several aspects of cognitive performance. Preliminary studies suggest that flavanols and chlorogenic acids can enhance cognitive performance. It is unknown if drinks formulated with flavanols and chlorogenic acids (without high sugar or caffeine) improve cognition or mood to a similar extent as caffeine. Coffeeberry beverage comparisons will be made to a flavored positive control beverage containing caffeine and a flavored placebo beverage.

Eligibility

Age

17 - 50 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Are older than 17 and under 50 years of age
•Self-report of good health

Exclusion Criteria

•Using any prescription medication including birth control
•Report hypersensitivity to caffeine
•Have visual impairment that cannot be corrected with glasses or contact lenses
•Report any food allergies
•Self-reported excessive leisure time physical activity (\> 7 strenuous bouts per week)
•the presence of current gastrointestinal, sleep, or psychiatric disorder,
•Report pregnancy/lactation, illegal drug use, smoker
•failure to demonstrate adequate minimal performance on lab, computer-based cognitive tasks.
•Participation in another clinical trial within past 30 days

Locations (1)

Exercise Psychology Laboratory University of Georgia

Athens, Georgia, United States

Key Dates

Start Date

June 28, 2016

Primary Completion Date

December 16, 2016

Completion Date

December 16, 2016

Last Updated

July 23, 2021

Enrollment

ACTUAL participants

Conditions

Fatigue, MentalAlertnessMoodMotivationCognitive Performance

Interventions

Cherry-flavored still beverage

DIETARY_SUPPLEMENT

Placebo cherry-flavored still beverage

OTHER

Transcutaneous Auricular Vagus Nerve Stimulation and Spirometry: Sham-Controlled Randomized Trial

NCT07482930

Vagus Nerve StimulationsSpirometry+3 more

View study

RECRUITINGPHASE2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT07072728

Adjustment DisorderAdjustment Disorder With Anxious Mood+9 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 23, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Coffeeberry on Mood, Motivation and Cognitive Performance

Inclusion Criteria

Exclusion Criteria

Transcutaneous Auricular Vagus Nerve Stimulation and Spirometry: Sham-Controlled Randomized Trial

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study

Physiological and Mood Changes After Walking in Green Spaces. A Comparison of Environments.

Suicide Specific Rumination in Veterans

Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course